The U.S. Department of Health and Human Services (HHS) is turning to venture capital to speed the development of medical devices to stave off or fight public health emergencies. HHS’s Biomedical Advanced Research and Development Authority (BARDA) plans to provide the nonprofit Global Health Investment Corporation (GHIC) with a minimum of $50 million over five years, with […]
U.S. Biomedical Advanced Research and Development Authority (BARDA)
Ortho Clinical Diagnostics wins nearly $53.7M BARDA contract for COVID-19 tests
Ortho Clinical Diagnostics (NSDQ:OCDX) announced that it received a $53.7 million government contract for its COVID-19 tests. Raritan, N.J.–based Ortho Clinical Diagnostics was awarded an undefinitized contract set to lead to a $53.7 million contract from the Biomedical Advanced Research and Development Authority (BARDA) as a continuation of the partnership between the two entities, according […]
Feds order 200M more vaccine doses from Pfizer, Moderna
U.S. government agencies announced that they purchased a total of 200 million additional doses of COVID-19 vaccines from Pfizer (NYSE:PFE) and Moderna (NSDQ:MRNA). The orders of 100 million doses from each of the only two FDA-authorized vaccines in the U.S. were made by the U.S. Health & Human Services Dept. (HHS) and the Defense Dept. (DoD). The […]
MedTech 100 roundup: Ringing in the New Year with another high
For the third time in the past four weeks, stocks within the medtech industry climbed to never-before-seen heights as 2021 reared its head. Previous highs have largely been a result of the FDA granting Moderna emergency use authorization for its vaccine candidate and its subsequent rollout to the U.S., joining the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), […]
Chembio lands $12.7M from BARDA for point-of-care test
Chembio Diagnostics (NSDQ:CEMI) announced that it received a $12.7 million contract from BARDA for its rapid COVID-19 test. Hauppauge, N.Y.-based Chembio said in a news release that the contract will support the development of and pursuit of FDA emergency use authorization (EUA) for its rapid, multi-plex DPP respiratory antigen panel point-of-care testing system ahead of […]
NIH announces more than $98M in contracts for new COVID-19 testing tech
The National Institutes of Health today announced six new contracts worth $98.35 million for COVID-19 testing approaches to improve sample collection, processing and results. NIH awarded the contracts in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) as part of the Rapid Acceleration of Diagnostics (RADx) initiative. They cover innovations including integration with […]
HHS gives Vaxxas $22M to support vaccine patch tech
Vaxxas announced today that it has received a $22 million award from the Biomedical Advanced Research and Development Authority (BARDA) at U.S. HHS to support a clinical study involving the company’s vaccine-delivery patch. The money will mostly pay for a Phase 1 clinical study in which Vaxxas’ high-density micro-array patch (HD-MAP) delivering pandemic influenza vaccine to […]
Feds target Medtronic in ventilator antitrust investigation
Medtronic (NYSE:MDT) is under investigation by the federal government for allegedly limiting competition in the ventilator business, the company acknowledged late yesterday. The civil antitrust probe grew out of complaints about device shortages during the coronavirus pandemic, according to a report by the Wall Street Journal. The Journal cited “people familiar with the matter” as saying […]
What are the top COVID-19 vaccine candidates?
As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]
J&J launches fourth large-scale COVID-19 vaccine trial
Johnson & Johnson (NYSE:JNJ) has begun enrollment of adult volunteers for a fourth Phase 3 clinical trial of a COVID-19 vaccine candidate. The National Institutes of Health announced today that J&J’s Janssen Pharmaceuticals COVID-19 vaccine candidate (JNJ-78436725) has begun the Phase 3 trial to evaluate if it can prevent symptomatic COVID-19 after a single dose regimen. Up […]
BARDA awards $12.9M to Ortho Clinical for coronavirus antigen test
Ortho Clinical Diagnostics announced that it received a nearly $12.9 million award from BARDA to support the development of its COVID-19 antigen test. Raritan, N.J.-based Ortho Clinical Diagnostics and the Biomedical Advanced Research and Development Authority (BARDA) are working together under a new contract as part of the government’s ongoing COVID-19 medical countermeasure development efforts, according […]
